Glutamine Metabolism in the Human Newborn

人类新生儿的谷氨酰胺代谢

基本信息

  • 批准号:
    6694076
  • 负责人:
  • 金额:
    $ 34.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-01-01 至 2007-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glutamine, an endogenously synthesized amino acid, has been variously considered "essential" or "conditionally essential" during acute illness and in very low birth weight (VLBW) infants. Several investigators have proposed the use of supplemental glutamine in VLBW babies in order to accelerate adaptation to extrauterine environment and recovery from related neonatal illness. However, there are no data actually quantifying changes in glutamine metabolism in relation to ontogeny or acute illness in full term and prematurely born infants. The specific aims of these studies are to examine the systemic and splanchnic metabolism of glutamine, and its relation to whole body protein/nitrogen and urea kinetics in the neonate. Since glutamine is synthesized de novo via a cataplerotic reaction of the tricarboxylic acid cycle from alphaketoglutarate and glutamate, it is hypothesized that its metabolism will be closely linked with the anaplerotic flux of substrates such as glucose and amino acids into the tricarboxylic acid cycle. Glutamine also serves as an important respiratory fuel for the enterocytes and the lymphocytes. It is hypothesized that enterally administered glutamine will be utilized locally in the splanchnic compartment in growing infants when the enterocytes (and lymphocytes) are proliferating. Furthermore, during neonatal adaptation and during recovery from acute illness in the low birth weight baby, glutamine will not be locally metabolized and will bypass the splanchnic compartment. These hypotheses will be examined by quantifying the kinetics of glutamine in zombination with measurements of the transamination of branched chain amino acids, protein turnover and urea synthesis. Stable isotopic tracers and gas chromatograph-mass spectrometric methods will be employed. These studies will systematically examine the interrelationship between the transamination of an essential amino acid, leucine, and the de novo synthesis of a dispensable amino acid, glutamine, during the critical period of ransition to extrauterine environment and during growth, and will provide a metabolic basis for nutritional management of low birth weight infants.
描述(由申请人提供):谷氨酰胺是一种内源合成的氨基酸,在急性疾病期间和极低出生体重(VLBW)婴儿中已被不同地认为是“必需的”或“条件必需的”。一些研究人员建议对极低出生体重婴儿补充谷氨酰胺,以加速对宫外环境的适应和相关新生儿疾病的恢复。然而,没有数据真正量化与足月和早产婴儿的个体发育或急性疾病相关的谷氨酰胺代谢变化。这些研究的具体目的是检查谷氨酰胺的全身和内脏代谢,及其与新生儿全身蛋白质/氮和尿素动力学的关系。由于谷氨酰胺是通过三羧酸循环的α酮戊二酸和谷氨酸的补补反应从头合成的,因此推测其代谢将与底物(例如葡萄糖和氨基酸)进入三羧酸循环的补补通量密切相关。谷氨酰胺还充当肠上皮细胞和淋巴细胞的重要呼吸燃料。据推测,当肠上皮细胞(和淋巴细胞)增殖时,肠内施用的谷氨酰胺将在生长中的婴儿的内脏腔室中局部利用。此外,在新生儿适应期间和低出生体重婴儿从急性疾病恢复期间,谷氨酰胺不会被局部代谢,并且会绕过内脏室。这些假设将通过测量支链氨基酸的转氨作用、蛋白质周转和尿素合成来量化僵尸化中谷氨酰胺的动力学来检验。将采用稳定同位素示踪剂和气相色谱-质谱法。这些研究将系统地研究在向宫外环境转移的关键时期和生长过程中必需氨基酸亮氨酸的转氨作用和非必需氨基酸谷氨酰胺的从头合成之间的相互关系,并为低出生体重儿的营养管理提供代谢基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SATISH C KALHAN其他文献

SATISH C KALHAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SATISH C KALHAN', 18)}}的其他基金

Maternal One Carbon Metabolism and Low Birth Weight Infant
母亲一碳代谢与低出生体重婴儿
  • 批准号:
    8512361
  • 财政年份:
    2013
  • 资助金额:
    $ 34.09万
  • 项目类别:
Sulfur Amino Acid Metabolism in NAFLD
NAFLD 中的硫氨基酸代谢
  • 批准号:
    7943016
  • 财政年份:
    2009
  • 资助金额:
    $ 34.09万
  • 项目类别:
Sulfur Amino Acid Metabolism in NAFLD
NAFLD 中的硫氨基酸代谢
  • 批准号:
    7653996
  • 财政年份:
    2009
  • 资助金额:
    $ 34.09万
  • 项目类别:
PROTEIN METABOLISM IN VERY LOW BIRTH WEIGHT INFANT: EFFECT OF ANAPLEROTIC FLUX
极低出生体重婴儿的蛋白质代谢:回补通量的影响
  • 批准号:
    7377989
  • 财政年份:
    2006
  • 资助金额:
    $ 34.09万
  • 项目类别:
METABOLISM OF METHIONINE IN THE NEWBORN INFANT
新生儿蛋氨酸的代谢
  • 批准号:
    7378013
  • 财政年份:
    2006
  • 资助金额:
    $ 34.09万
  • 项目类别:
METABOLISM OF GLUTAMINE IN NEWBORN INFANTS
新生儿谷氨酰胺的代谢
  • 批准号:
    7202708
  • 财政年份:
    2005
  • 资助金额:
    $ 34.09万
  • 项目类别:
PROTEIN METABOLISM IN VERY LOW BIRTH WEIGHT INFANT: EFFECT OF ANAPLEROTIC FLUX
极低出生体重婴儿的蛋白质代谢:回补通量的影响
  • 批准号:
    7202703
  • 财政年份:
    2005
  • 资助金额:
    $ 34.09万
  • 项目类别:
Metabolism of arginine in the newborn infant
新生儿精氨酸的代谢
  • 批准号:
    6974918
  • 财政年份:
    2004
  • 资助金额:
    $ 34.09万
  • 项目类别:
Metabolism of glutamine in newborn infants
新生儿谷氨酰胺的代谢
  • 批准号:
    6974915
  • 财政年份:
    2004
  • 资助金额:
    $ 34.09万
  • 项目类别:
Protein metabolism in very low birth weight infant: Effect of anaplerotic flux
极低出生体重婴儿的蛋白质代谢:回补通量的影响
  • 批准号:
    6974905
  • 财政年份:
    2004
  • 资助金额:
    $ 34.09万
  • 项目类别:

相似国自然基金

一碳代谢(One carbon metabolism)介导上调的 PD1/PDL1 驱动 肿瘤免疫逃逸
  • 批准号:
    2024JJ9491
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Gatekeeping glycan metabolism in the human gut microbiome
人类肠道微生物组中的聚糖代谢把关
  • 批准号:
    10737225
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
Differential changes in energy metabolism in response to mechanical tension give rise to human scaring heterogeneity
响应机械张力的能量代谢的差异变化导致人类恐惧异质性
  • 批准号:
    10660416
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
New drugs and new targets: in search of new classes of drugs that inhibit rhodoquinone-dependent metabolism, an unusual form of anaerobic metabolism that allows parasites to survive in the human gut
新药和新靶标:寻找抑制罗多醌依赖性代谢的新型药物,这是一种不寻常的厌氧代谢形式,可让寄生虫在人体肠道中生存
  • 批准号:
    479299
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
    Operating Grants
Metabolism of cancer chemotherapeutics by the human gut microbiome
人类肠道微生物组对癌症化疗药物的代谢
  • 批准号:
    10635361
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
Control mechanisms of 5-hydroxymethylcytosine metabolism in human cells
人体细胞5-羟甲基胞嘧啶代谢的控制机制
  • 批准号:
    10629908
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
Establishment of culture methods of human liver organoids for nutrition metabolism studies
用于营养代谢研究的人肝脏类器官培养方法的建立
  • 批准号:
    23K05070
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Construction of drug transport/metabolism research models by improving functions of human tissue-derived cells
通过改善人体组织来源细胞的功能构建药物转运/代谢研究模型
  • 批准号:
    23H02646
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dissecting the molecular basis of dietary fibre metabolism by beneficial Bacteroidetes of the human gut microbiota
剖析人类肠道微生物群有益拟杆菌膳食纤维代谢的分子基础
  • 批准号:
    478205
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
    Operating Grants
Investigating the effects of APOE and APOE-related AD risk genes on human microglia activity and lipid metabolism in aging and disease
研究 APOE 和 APOE 相关 AD 风险基因对衰老和疾病过程中人类小胶质细胞活性和脂质代谢的影响
  • 批准号:
    10900992
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
Mitochondrial metabolism as a target for human metabolites of dietary anthocyanins
线粒体代谢作为人类膳食花青素代谢物的靶标
  • 批准号:
    2869083
  • 财政年份:
    2023
  • 资助金额:
    $ 34.09万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了